Hereditary Cancer Panel denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for hereditary cancer panel are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Prior Authorization for Hereditary Cancer Panel Testing

UnitedHealthcare requires prior authorization for hereditary cancer panel testing as a utilization management step. The prior authorization process is meant to confirm — before the test is performed — that the patient meets UHC's coverage criteria. Denials at this stage typically occur because the authorization request was submitted without adequate clinical documentation, because the request was not submitted at all before testing occurred (resulting in a retrospective denial), or because the submitted information did not clearly map to UHC's eligibility criteria.

## Why This Denial Is Appealable

A prior-authorization denial is not a final determination that the service is non-covered. It is a finding that the submitted documentation was insufficient or that criteria were not met at the time of review — both of which are contestable. If the ordering clinician believes the patient meets UHC's published criteria, a properly documented appeal presenting that evidence directly can reverse the denial. Retrospective denials (testing already completed without prior auth) carry an additional procedural argument if the patient was not clearly informed of the authorization requirement.

## Your Federal Appeal Rights

• Internal appeal: Under ERISA §503 (employer plans) or applicable state law, you are entitled to a full-and-fair review of the authorization denial. File within the timeframe on the denial notice.
• Expedited appeal: If testing is time-sensitive — for example, results are needed to guide imminent surgical planning — request an expedited internal appeal, which plans must resolve within 72 hours for urgent pre-service requests.
• External review: After exhausting internal remedies, ACA §2719 provides the right to independent external review, typically within approximately four months of the final internal denial.

## Concrete Appeal Steps and Timeline

1. Pull the exact denial letter and identify every stated reason for the authorization denial. 2. Retrieve UHC's current Medical Policy for hereditary cancer testing from uhcprovider.com. 3. Work with the ordering clinician to prepare documentation that addresses each stated deficiency. 4. Resubmit as an internal appeal (not a new PA request) to preserve your appeal rights and timeline. 5. If denied again, file for external IRO review within the window on the denial letter.

## Documentation to Gather

• Personal and family cancer history: Detailed pedigree with relationship, cancer type, and age of diagnosis for each affected relative, compiled by the ordering clinician or a genetic counselor.
• Prior genetic counseling: Documentation of a genetics consultation, if one occurred, establishing clinical context.
• Prescriber letter of medical necessity: A specific statement — not a form letter — explaining how this patient meets each of UHC's published prior-authorization criteria.
• Clinical management plan: A brief statement on how test results will alter clinical management (surgical planning, surveillance frequency, cascade testing of relatives, etc.).
• Diagnosis and chart notes: Supporting records confirming the indication, including any relevant pathology, oncology, or primary care notes.

## Criteria-Mapping Structure

Obtain UHC's prior-authorization criteria checklist and reproduce it verbatim. For each criterion, cite the specific chart evidence — date, document type, and the exact finding — that satisfies it. Submit this as the cover page of your appeal. Reviewers are required to address each criterion; a structured mapping makes a summary re-denial far more difficult to sustain.